Dr. Yago L. Nieto
Claim this profileM D Anderson Cancer Center
Studies T-Cell Lymphoma
Studies Cancer
5 reported clinical trials
19 drugs studied
Area of expertise
1T-Cell Lymphoma
CD30 positive
HLA-A
HLA-B
2Cancer
CD30 positive
HLA-A
HLA-B
Affiliated Hospitals
More about Yago L. Nieto
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Yago L. Nieto has experience with
- Busulfan
- Rituximab
- Gemcitabine
- Melphalan
- Peripheral Blood Stem Cell Transplantation
- Vorinostat
Breakdown of trials Yago L. Nieto has run
T-Cell Lymphoma
Cancer
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yago L. Nieto specialize in?
Yago L. Nieto focuses on T-Cell Lymphoma and Cancer. In particular, much of their work with T-Cell Lymphoma has involved CD30 positive patients, or patients who are HLA-A.
Is Yago L. Nieto currently recruiting for clinical trials?
No, Yago L. Nieto is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Yago L. Nieto has studied deeply?
Yes, Yago L. Nieto has studied treatments such as Busulfan, Rituximab, Gemcitabine.
What is the best way to schedule an appointment with Yago L. Nieto?
Apply for one of the trials that Yago L. Nieto is conducting.
What is the office address of Yago L. Nieto?
The office of Yago L. Nieto is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.